Shares of Novavax are looking weak and in need of a booster, according to the technicals.
Let's look at the charts and indicators.
The technical setup of the healthcare provider's stock is bullish.
The charts don't look promising for GDRX.
The shares took another hit today after sinking the past 12 months.
Here's my trade prescription for Medical Properties Trust, an under-the-radar Real Estate Investment Trust.
With the shares rallying, let's check how the charts are doing.
The technical history of the stock is limited but buyers appear more aggressive than sellers.
I have no patience moving forward with a large firm standing on a sloppy book, trying to digest an acquisition it needs to make, but can only questionably afford.
The charts for this drug developer are starting to take shape.